- £137.09m
- £127.84m
- £32.16m
- 83
- 16
- 55
- 49
REG - Diaceutics PLC - Board Changes
AnnouncementREG - Diaceutics PLC - Revenue growth of 24% in H1 with 55% now recurring
AnnouncementREG - Diaceutics PLC - Senior Management Appointments
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/SIP and Total Voting Rights
AnnouncementREG - Diaceutics PLC - Result of AGM
AnnouncementRCS - Diaceutics PLC - "Precision Medicine in Oncology " Virtual Event
AnnouncementREG - Diaceutics PLC - Diaceutics - Capital Markets Event
AnnouncementREG - Diaceutics PLC - Notice of AGM and Posting of Annual Report
AnnouncementREG - Diaceutics PLC - Data to be Presented at 2024 ASCO Annual Meeting
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/SIP and Total Voting Rights
AnnouncementREG - Diaceutics PLC - Director / PDMR Shareholding
AnnouncementREG - Diaceutics PLC - Revenue growth of 22% & order book growth of 57%
AnnouncementREG - Diaceutics PLC - Two New Enterprise-Wide Engagements
AnnouncementREG - Diaceutics PLC - Diaceutics - Capital Markets Event
AnnouncementREG - Diaceutics PLC - Notice of Results & Presentations
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/SIP and TVR
AnnouncementREG - Diaceutics PLC - Appointment of Amie Mc Neice as VP of Marketing
AnnouncementREG - Diaceutics PLC - Block Listing Return
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
Announcement